Suprachoroidal drug delivery promises targeted impact, but nothing comes without compromise. Formulation, delivery route and device design are tightly interlinked, with every decision shaping risk and reach.

David Cottenden from TTP’s Drug Delivery team explores how smarter delivery approaches can unlock the full potential of the suprachoroidal space.

‍